Post-earnings recap
Reported
Wed, Oct 16, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported an EPS of $0.84, slightly missing expectations. The stock reacted with a minor decline of 0.24%. The lack of revenue data and management commentary leaves investors with limited insights into the company's performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.84 | N/A | -0.88% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—